SUVRETTA CAPITAL MANAGEMENT, LLC

Position in RCUS — Arcus Biosciences, Inc.

CIK 1569064 New York, NY

Position in RCUS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$108,669,448

-$14,981,038 QoQ

Shares Held

5,030,993

-3.0% QoQ

Ownership

4.00%

of shares outstanding

% of Portfolio

2.97%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. RCUS ranks #9 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc.	12,327,000	$290,424,120
2	MANE	Veradermics, Inc	4,168,970	$263,270,455
3	PVLA	Palvella Therapeutics, Inc.	1,153,496	$143,783,276
4	APLS	Apellis Pharmaceuticals, Inc.	3,518,471	$141,548,088
5	LEGN	Legend Biotech Corp	7,581,029	$137,140,814
6	BNTC	Benitec Biopharma Inc.	11,548,351	$122,989,938
7	CAPR	Capricor Therapeutics, Inc.	3,818,600	$116,085,440
8	IMTX	Immatics N.V.	11,190,129	$110,110,869

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$108,669,448	5,030,993	-3.0%	Shares	Sole	2026-05-15
2025-12-31	$123,650,486	5,188,858	+40.7%	Shares	Sole	2026-02-17
2025-09-30	$50,168,468	3,688,858	0.0%	Shares	Sole	2025-11-14
2025-06-30	$30,027,304	3,688,858	+44.0%	Shares	Sole	2025-08-14
2025-03-31	$20,103,096	2,560,904	+344.5%	Shares	Sole	2025-05-15
2024-12-31	$8,578,962	576,156	-13.2%	Shares	Sole	2025-02-14
2024-09-30	$10,146,489	663,603	-30.7%	Shares	Sole	2024-11-14
2024-06-30	$14,579,739	957,304	0.0%	Shares	Sole	2024-08-14
2024-03-31	$18,073,899	957,304	0.0%	Shares	Sole	2024-05-15
2023-12-31	$18,284,506	957,304	+60.3%	Shares	Sole	2024-02-14
2023-09-30	$10,717,927	597,099	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.